MaxioCel® Advanced Wound Care Solutions

MaxioCel® is an advanced wound care portfolio based on 100% chitosan and Bioactive Microfibre Gelling™ (BMG) technology, designed to support optimal healing across acute, chronic, and post-operative wounds. A. MaxioCel® Advanced Wound Dressings ProductRange MX0505 | MX0510 | MX1010 | MX1515 | MX2030 | MX4545 Indications • Chronic wounds • Diabetic foot ulcers • Pressure ulcers • Burns and large surface wounds Key Features • High exudate absorption and retention • Pain-free removal • Promotes granulation tissue formation • Maintains a moist wound environment Certifications • US FDA 510(k) Cleared • CE Certified • Available in sterile packs • NSN available for MX 2030 and MX4545 B. MaxioCel® Wound Gel (MG50) (Available in limited markets) Indications • Adjunct therapy for acute and chronic wounds Key Features • Forms a protective chitosan gel layer • Prevents wound dehydration • Antimicrobial action with PHMB • Helps reduce pain and improve scar appearance ________________________________________ C. MaxioCel® Wound Cleansing Solution (MS100) (Available in limited markets) Indications • Wound irrigation and cleansing prior to dressing application Key Features • Chitosan-based sterile solution • Helps cleanse wound bed • Supports moist wound healing environment • Assists in autolytic debridement ________________________________________ D. MaxioCel® Surgical Site Dressings (SSD) Product Range • MXSD1015 • MXSD1030 Indications • Post-operative wound coverage Key Features • Bioactive Microfibre Gelling™ (BMG) technology • Absorbs up to 30× its weight in exudate • Flexible waterproof backing • High wet strength; remains intact during dressing change